1. Home
  2. NCSM vs ANTX Comparison

NCSM vs ANTX Comparison

Compare NCSM & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCS Multistage Holdings Inc.

NCSM

NCS Multistage Holdings Inc.

HOLD

Current Price

$43.00

Market Cap

170.3M

Sector

Energy

ML Signal

HOLD

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$4.72

Market Cap

170.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCSM
ANTX
Founded
2006
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
170.3M
170.6M
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
NCSM
ANTX
Price
$43.00
$4.72
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$2.00
AVG Volume (30 Days)
40.6K
233.5K
Earning Date
04-29-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
239.22
32.56
EPS
N/A
N/A
Revenue
$142,471,000.00
N/A
Revenue This Year
$5.57
N/A
Revenue Next Year
$4.81
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$28.65
$1.00
52 Week High
$87.36
$6.91

Technical Indicators

Market Signals
Indicator
NCSM
ANTX
Relative Strength Index (RSI) 33.31 61.13
Support Level $35.62 $1.06
Resistance Level $43.62 $5.14
Average True Range (ATR) 4.58 0.40
MACD -1.56 -0.04
Stochastic Oscillator 7.82 65.04

Price Performance

Historical Comparison
NCSM
ANTX

About NCSM NCS Multistage Holdings Inc.

NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completion, and field development strategies. The company provides its products and services to E&P companies for use in onshore and offshore wells, predominantly those drilled with horizontal laterals in unconventional and conventional oil and natural gas formations. It also provides tracer diagnostics services and sells products for well construction including casing buoyancy systems, liner hanger systems and toe initiation sleeves, along with certain complementary products from third parties. The company operates in the United States, Canada and other countries, with the majority of its revenue generated from Canada.

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

Share on Social Networks: